Real World Clinical Outcomes for Metastatic Non-Small Cell Lung Cancer (mNSCLC) at IRST Italy

被引:0
|
作者
Altini, M. [1 ]
Massa, I. [1 ]
Balzi, W. [1 ]
Gentili, N. [1 ]
Foca, F. [1 ]
Danesi, V. [1 ]
Manunta, S. [1 ]
Ejzykowicz, F. [2 ]
Chandwani, S. [3 ]
Burgio, M. [1 ]
Cravero, P. [1 ]
Verlicchi, A. [1 ]
Bronte, G. [1 ]
Crino, L. [1 ]
Delmonte, A. [1 ]
机构
[1] IRCCS, Ist Sci Romagnolo Studio & Cura Tumor Irst, Meldola, Italy
[2] Merck & Co Inc, Oncol Prod Line, Core, Kenilworth, NJ USA
[3] Merck & Co Inc, Ctr Observat & Real World Evidence, Kenilworth, NJ USA
关键词
treatment pattern; real-world study; Outcomes;
D O I
10.1016/j.jtho.2019.08.2369
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EP1.16-04
引用
收藏
页码:S1065 / S1066
页数:2
相关论文
共 50 条
  • [1] Real-world treatment patterns in patients with non-metastatic non-small cell lung cancer in Greece: the 'EVIDENCE' study
    Mountzios, Giannis
    Lampaki, Sofia
    Linardou, Helena
    Georgoulias, Vassilis
    Mavroudis, Dimitrios
    Anevlavis, Stavros
    Charpidou, Andriani
    Lykka, Maria
    Spyratos, Dionysis
    Sarris, Evangelos G.
    Somarakis, Alvertos
    Papista, Christina
    Glentis, Alexandros
    Nikolaou, Aristeidis
    Paparepa, Zoe
    Papageorgiou, Foteini
    Syrigos, Konstantinos N.
    FUTURE ONCOLOGY, 2025, 21 (04) : 447 - 462
  • [2] Real-World Clinical Impact of Immune Checkpoint Inhibitors in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer After Platinum Chemotherapy
    Schwartzberg, Lee
    Korytowsky, Beata
    Penrod, John R.
    Zhang, Ying
    Le, T. Kim
    Batenchuk, Cory
    Krug, Lee
    CLINICAL LUNG CANCER, 2019, 20 (04) : 287 - +
  • [3] Pattern of Treatment Initiation and Outcomes for Patients With Metastatic Non-small Cell Lung Cancer in Ontario
    Ding, Jerry W.
    Hussein, Abdulkadir A.
    Huang, Zhong Ren
    Ehsan, Kamran
    Moudgil, Devinder
    Kulkarni, Swati
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (04)
  • [4] Clinical outcomes of KRAS-mutant non-small cell lung cancer under untargeted therapeutic regimes in the real world: a retrospective observational study
    Wang, Ming-Ming
    Zhang, Yong
    Wu, Shuo
    Zhang, Si-Yuan
    Shan, Hui-Liang
    Yang, Xue-Min
    Xu, Xi
    Song, Li-Qiang
    Qu, Shuo-Yao
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (10) : 2030 - 2039
  • [5] Immunotherapy for Metastatic Non-Small Cell Lung Cancer: Real-World Data from an Academic Central and Eastern European Center
    Ivanovic, Marija
    Knez, Lea
    Herzog, Ana
    Kovacevic, Mile
    Cufer, Tanja
    ONCOLOGIST, 2021, 26 (12) : E2143 - E2150
  • [6] A Real-World Study: Efficacy and Safety of Anlotinib for Advanced Non-Small Cell Lung Cancer
    Wang, J.
    Yi, T.
    Dong, Y.
    Ran, R.
    Cao, F.
    Li, Y.
    Luo, Z.
    Xu, Y.
    Fu, Y.
    Kuang, L.
    Chen, G.
    Qu, G.
    Yin, Y.
    Li, J.
    Xu, X.
    Chen, Y.
    Song, Q.
    Chu, Q.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1071 - S1071
  • [7] Efficacy and Safety of Anlotinib in Advanced Non-Small Cell Lung Cancer: A Real-World Study
    Zhang, Kun
    Ma, Xiya
    Gao, Hongjun
    Wang, Hong
    Qin, Haifeng
    Yang, Shaoxing
    Liu, Xiaoqing
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 3409 - 3417
  • [8] Real-World Analysis of the Impact of Radiotherapy on Immunotherapy Efficacy in Non-Small Cell Lung Cancer
    Onn, Amir
    Gottfried, Teodor
    Stemmer, Amos
    Appel, Sarit
    Lawrence, Yaacov R.
    Urban, Damien
    Beller, Tamar
    Daher, Sameh
    Bar, Jair
    CANCERS, 2021, 13 (11)
  • [9] Intrapleural treatment in patients with non-small cell lung cancer with malignant pleural effusions in the real world
    Pan, Pengfei
    Wu, Fengjuan
    Xu, Zhiyun
    Ji, Xiang
    Qi, Qian
    Huang, Xiaomin
    Zhao, Ruyue
    Liu, Mingtao
    Jiang, Peng
    Li, Yu
    Xu, Lisheng
    THORACIC CANCER, 2021, 12 (24) : 3416 - 3425
  • [10] Management and Outcomes of Newly Diagnosed Non-Small Cell Lung Cancer Patients with Brain Metastases: A Real-World Study in Japan
    Yoshida, Hironori
    Kim, Young Hak
    Iwatsubo, Shigeaki
    Sakaguchi, Chikara
    Sakamori, Yuichi
    Nagai, Hiroki
    Ozasa, Hiroaki
    Mio, Tadashi
    Hirai, Toyohiro
    ONCOLOGY, 2020, 98 (07) : 460 - 467